- ICH GCP
- 미국 임상 시험 레지스트리
- 임상시험 NCT02403037
Auricular Acupressure for Chemotherapy-Induced Nausea and Vomiting in Female Breast Cancer Patients
The Effects of Auricular Acupressure on Chemotherapy-Induced Nausea and Vomiting in Female Breast Cancer Patients: A Pilot Randomized Controlled Trial
To evaluate the feasibility of a three-parallel-arm, placebo-controlled randomized trial using a standard auricular acupressure protocol for managing nausea and vomiting in a homogenous group of female breast cancer patients undergoing chemotherapy.
The null hypotheses of this study are: (1) There will be no significant difference in acute/delayed nausea and vomiting among groups during the intervention period; (2) There will be no significant difference in anticipatory nausea and vomiting among groups before the second cycle of chemotherapy; (3) There will be no significant difference in quality of life status among groups at the end of the first cycle of chemotherapy.
연구 개요
상태
상세 설명
Chemotherapy-induced nausea and vomiting (CINV) is one of the most common and distressing side-effects among cancer patients undergoing chemotherapy. Despite steady progresses in antiemetic prophylaxis and treatment during the past decades, approximately half of cancer patients receiving moderately to highly emetogenic chemotherapy still experience significant nausea and vomiting. Considering the facts that CINV is difficult to be completely controlled by antiemetics along, healthcare professionals has explored the role of non-pharmacological interventions as adjunctive therapy for controlling CINV. Among which, auricular therapy (AT) is a promising approach but the evidence has still not been concluded.
The aim of this study is to test the feasibility of a randomized controlled trial using auricular acupressure protocol for managing nausea and vomiting in female breast cancer patients undergoing chemotherapy. The objectives of this study will be: (1) to pilot the methodological procedure of the randomized controlled trial using a standard auricular acupressure protocol for controlling CINV; (2) to determine the recruitment rate and attrition rate during the whole study period; (3) to determine the feasibility of the study questionnaires and auricular acupressure protocol to the study participants; (4) to identify potential adverse events associated with auricular acupressure; (5) to preliminarily examine the effects of auricular acupressure on CINV and QoL in female breast cancer patients receiving chemotherapy; (6) to explore patients' experience in completing the trial and receiving the intervention; and (7) to refine the study protocol for a future multicenter, large-scale randomized controlled trial.
A three-parallel-arm, placebo-controlled randomized pilot study will be adopted. One hundred and fourteen breast cancer patients scheduled to receive the first cycle of chemotherapy will be recruited from three provincial hospitals in Fuzhou, China, and will be randomly assigned to one of the three groups: the true AT group, the sham AT group or the standard care group. Participants in the true AT group will receive standard anti-emetic medications plus a 5-day auricular acupressure at the specific ear acupoints, participants in the sham AT group will receive standard anti-emetic medications plus a 5-day auricular acupressure at the same acupoints as in the true AT group without any acupoint stimulation, while participants in the standard care group will only be provided with the standard anti-emetic medications. The feasibility outcomes will be the recruitment rate and consent rate during the recruitment stage, the attrition rate during the whole study period, feasibility of the study questionnaires and auricular acupressure protocol to the study participants, and AT-related adverse events. The future main study outcomes will also be measured including acuteCINV, delayed CINV, anticipatory CINV, and quality of life. After completing the pilot clinical trial, a nested qualitative interview will be conducted to explore participants' experience in completing the trial and receiving the intervention.
연구 유형
등록 (실제)
단계
- 해당 없음
연락처 및 위치
연구 장소
-
-
Fujian
-
Fuzhou, Fujian, 중국, 350014
- Fujian Provincial Cancer Hospital
-
Fuzhou, Fujian, 중국, 350003
- The Second People's Hospital of Fujian Province
-
Fuzhou, Fujian, 중국, 350004
- The First People's Hospital of Fujian Province
-
-
참여기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
설명
Inclusion Criteria:
- Adult female patients aged above 18 years old;
- A diagnosis of breast cancer stage I-III;
- Chemotherapy- naive;
- Auricular therapy-naive;
- Be able to communicate in Chinese mandarin;
- Have at least completed a primary school education;
- Agree to participate in the study and be willing to give written informed consent;
- Be scheduled to receive the first cycle of chemotherapy with moderately-high to highly emetogenic potentials;
- Be provided with standard antiemetic medications during chemotherapy.
Exclusion Criteria:
- Extremely weak, disabled or immunocompromised cancer patients;
- Be unable to follow the study instructions to do AT intervention or other research procedures;
- Have concurrent radiotherapy or other kinds of antineoplastic therapy;
- Currently take part in clinical studies on anti-emetic medications or other kinds of non-pharmacological interventions to control CINV, or other studies which are believed to produce potential interactions with this AT trial;
- Have other health problems which may affect the symptoms of CINV such as gastrointestinal disease, liver disease, migraine, tinnitus and Ménière's disease, etc.;
- Ear skin problems which are not appropriate for auricular acupressure including ear infections, ear scars and rashes, ear frostbite, and ear abscess, etc.
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 치료
- 할당: 무작위
- 중재 모델: 병렬 할당
- 마스킹: 삼루타
무기와 개입
참가자 그룹 / 팔 |
개입 / 치료 |
---|---|
실험적: True Auricular Acupressure Group
Participants in this group will receive standard antiemetics before and during chemotherapy, and a 5-day auricular acupressure treatment protocol for controlling nausea and vomiting during the first cycle of chemotherapy.
|
A 5-day auricular acupressure at the specific ear acupoints using vaccaria seeds.
다른 이름들:
5-HT3 receptor antagonists and/or Dexamethasone will be administered to manage chemotherapy-induced nausea and vomiting.
다른 이름들:
|
가짜 비교기: Sham Auricular Acupressure Group
Participants in this group will receive standard antiemetic medications before and during chemotherapy, and a 5-day sham auricular acupressure intervention protocol during the first cycle of chemotherapy.
|
5-HT3 receptor antagonists and/or Dexamethasone will be administered to manage chemotherapy-induced nausea and vomiting.
다른 이름들:
A 5-day sham auricular acupressure at the same acupoints as in the true auricular acupressure arm using Junci Medulla but no pressure will be applied.
다른 이름들:
|
다른: Standard Care Group
Participants in this group will only receive standard anti-emetic treatment before and during chemotherapy.
|
5-HT3 receptor antagonists and/or Dexamethasone will be administered to manage chemotherapy-induced nausea and vomiting.
다른 이름들:
|
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
---|---|---|
Recruitment Rate
기간: Through study completion, an average of 1 year and 4 months
|
Feasibility outcome
|
Through study completion, an average of 1 year and 4 months
|
Consent Rate
기간: Through study completion, an average of 1 year and 4 months
|
Feasibility outcome
|
Through study completion, an average of 1 year and 4 months
|
Attrition Rate
기간: Through study completion, an average of 1 year and 4 months
|
Feasibility outcome
|
Through study completion, an average of 1 year and 4 months
|
Feasibility of the Study Questionnaires and Auricular Acupressure Protocol
기간: Through study completion, an average of 1 year and 4 months
|
Feasibility outcome
|
Through study completion, an average of 1 year and 4 months
|
Potential Adverse Events associated with Auricular Acupressure
기간: During the 5-day intervention period
|
Feasibility outcome
|
During the 5-day intervention period
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
---|---|---|
Occurrence of Acute Vomiting
기간: The 2nd day of the first chemotherapy cycle
|
Secondary outcome
|
The 2nd day of the first chemotherapy cycle
|
Frequency of Acute Vomiting
기간: The 2nd day of the first chemotherapy cycle
|
Secondary outcome
|
The 2nd day of the first chemotherapy cycle
|
Occurrence of Acute Nausea
기간: The 2nd day of the first chemotherapy cycle
|
Secondary outcome
|
The 2nd day of the first chemotherapy cycle
|
Severity of Acute Nausea
기간: The 2nd day of the first chemotherapy cycle
|
Secondary outcome
|
The 2nd day of the first chemotherapy cycle
|
Occurrence of Delayed Vomiting
기간: The 6th day of the first chemotherapy cycle
|
Secondary outcome
|
The 6th day of the first chemotherapy cycle
|
Frequency of Delayed Vomiting
기간: The 6th day of the first chemotherapy cycle
|
Secondary outcome
|
The 6th day of the first chemotherapy cycle
|
Occurrence of Delayed Nausea
기간: The 6th day of the first chemotherapy cycle
|
Secondary outcome
|
The 6th day of the first chemotherapy cycle
|
Severity of Delayed Nausea
기간: The 6th day of the first chemotherapy cycle
|
Secondary outcome
|
The 6th day of the first chemotherapy cycle
|
Anticipatory Nausea and Vomiting
기간: The 1st day of the second chemotherapy cycle
|
The measure is a composite
|
The 1st day of the second chemotherapy cycle
|
Quality of Life Status
기간: The 21st day of the first chemotherapy cycle
|
Secondary outcome
|
The 21st day of the first chemotherapy cycle
|
공동 작업자 및 조사자
수사관
- 수석 연구원: Lorna SUEN, PhD, The Hong Kong Polytechnic University
간행물 및 유용한 링크
연구 기록 날짜
연구 주요 날짜
연구 시작
기본 완료 (실제)
연구 완료 (실제)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (추정)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
추가 관련 MeSH 약관
기타 연구 ID 번호
- HSEARS20150213001
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .
유방 신생물에 대한 임상 시험
True auricular acupressure에 대한 임상 시험
-
Jinling Hospital, China아직 모집하지 않음두개내 동맥류 | 딥 러닝 | CT 혈관조영술 | 이중 바인딩 상호 작용중국
-
University Health Network, TorontoUniversity of British Columbia; University of Toronto; Dalhousie University; Canadian Cancer... 그리고 다른 협력자들모집하지 않고 적극적으로
-
Shanghai General Hospital, Shanghai Jiao Tong University...Duke University; Rutgers University; Tsinghua University완전한